Repurposed FDA Medicines for Unsatisfied Needs for sale

The company is working to repurpose drugs that have already received FDA approval and use them in the future for other problems, including the treatment of Parkinson’s disease, Alzheimer’s, the fight against COVID-19, and more.

Extensive IT database with pending patents and patents pending. Re-use of drugs that have already received the appropriate approval significantly reduces the risk of failure. In addition, development costs are significantly reduced. The firm is funded by third-party founders. There are no debts. Performance and effectiveness are tested by a team of experienced and qualified medical researchers.